ATP5L antibody (AA 2-103) (FITC)
Quick Overview for ATP5L antibody (AA 2-103) (FITC) (ABIN7144862)
Target
See all ATP5L AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 2-103
-
Cross-Reactivity
- Human
-
Purification
- >95%, Protein G purified
-
Immunogen
- Recombinant Human ATP synthase subunit g, mitochondrial protein (2-103AA)
-
Isotype
- IgG
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- ATP5L (ATP Synthase, H+ Transporting, Mitochondrial Fo Complex, Subunit G (ATP5L))
-
Alternative Name
- ATP5L
-
Background
-
Background: Mitochondrial membrane ATP synthase (F(1)F(0) ATP synthase or Complex V) produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. F-type ATPases consist of two structural domains, F(1) - containing the extramembraneous catalytic core, and F(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. Part of the complex F(0) domain. Minor subunit located with subunit a in the membrane.
Aliases: ATP synthase subunit g antibody, ATP synthase, H+ transporting, mitochondrial F1F0, subunit g antibody, ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G antibody, ATP5L antibody, ATP5L_HUMAN antibody, ATPase subunit g antibody, F1Fo ATP synthase complex Fo membrane domain g subunit antibody, mitochondrial antibody
-
UniProt
- O75964
-
Pathways
- Proton Transport, Ribonucleoside Biosynthetic Process, SARS-CoV-2 Protein Interactome
Target
-